Navin Fluorine International Ltd

Navin Fluo.Intl. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Navin Fluorine International Ltd

₹ 7,082 2.51%
19 May 3:36 p.m.
nfil.in BSE: 532504 NSE: NAVINFLUOR
About

Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]

Key Points

Overview[1]
NFIL, a part of the Padmanabh Mafatlal group, is present in the fluorochemical industry since 1967 and is one of the largest specialty fluorochemical companies and a pioneer in manufacturing of refrigerant gases in India. NFIL’s product portfolio comprises 60+ fluorinated compounds, with them finding application in various industries, like agrochemicals, pharmaceuticals, aluminium smelting, refrigeration, metal processing, abrasives, glass and ceramics. The company is currently headed by second-generation entrepreneur, Vishad Mafatlal, who has over 25 years’ experience in textile and chemical sectors

Website BSE NSE
  • Market Cap ₹ 36,325 Cr.
  • Current Price ₹ 7,082
  • High / Low ₹ 7,208 / 4,212
  • Stock P/E 54.3
  • Book Value ₹ 775
  • Dividend Yield 0.22 %
  • ROCE 21.4 %
  • ROE 20.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 22.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.1%

Cons

  • Stock is trading at 9.13 times its book value
  • Working capital days have increased from 82.8 days to 178 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 Nifty 500 Nifty Smallcap 100 Nifty Alpha 50 BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
697 491 472 500 602 524 519 606 701 725 758 892 938
495 377 373 424 492 423 411 459 522 519 512 585 617
Operating Profit 202 114 98 76 110 100 107 147 179 207 246 308 321
OPM % 29% 23% 21% 15% 18% 19% 21% 24% 26% 29% 32% 34% 34%
4 8 23 64 13 10 11 10 12 14 18 -5 31
Interest 14 19 20 18 17 16 14 20 28 30 30 28 29
Depreciation 8 21 24 25 26 27 28 30 35 35 37 36 41
Profit before tax 184 82 77 97 79 68 77 108 127 155 198 238 282
Tax % 26% 25% 22% 20% 11% 25% 23% 23% 25% 24% 25% 22% 25%
136 62 61 78 70 51 59 84 95 117 148 185 213
EPS in Rs 27.50 12.41 12.22 15.74 14.19 10.32 11.86 16.86 19.15 23.62 28.96 36.18 41.48
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
592 680 742 913 996 1,062 1,179 1,453 2,077 2,065 2,349 3,314
519 561 582 693 777 794 870 1,098 1,527 1,666 1,816 2,232
Operating Profit 72 118 159 220 219 268 309 356 550 399 534 1,082
OPM % 12% 17% 21% 24% 22% 25% 26% 24% 26% 19% 23% 33%
29 23 55 88 34 29 94 38 36 107 44 59
Interest 3 4 3 1 1 2 2 2 28 75 78 118
Depreciation 20 22 30 40 28 37 44 48 63 96 119 149
Profit before tax 78 116 182 266 224 258 358 344 496 336 380 873
Tax % 26% 28% 25% 32% 34% -56% 31% 24% 24% 19% 24% 24%
58 84 137 180 149 409 258 263 375 270 289 664
EPS in Rs 11.18 17.08 27.88 36.43 30.15 82.57 52.02 53.09 75.68 54.56 58.19 129.46
Dividend Payout % 29% 25% 23% 27% 26% 13% 21% 21% 16% 27% 12% 12%
Compounded Sales Growth
10 Years: 17%
5 Years: 23%
3 Years: 17%
TTM: 41%
Compounded Profit Growth
10 Years: 23%
5 Years: 22%
3 Years: 22%
TTM: 132%
Stock Price CAGR
10 Years: 33%
5 Years: 17%
3 Years: 15%
1 Year: 60%
Return on Equity
10 Years: 17%
5 Years: 15%
3 Years: 15%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 578 636 825 974 1,063 1,402 1,624 1,834 2,175 2,373 2,616 3,964
61 82 19 13 4 1 25 121 861 1,368 1,466 1,272
203 228 324 259 231 215 239 420 484 626 738 1,133
Total Liabilities 852 955 1,177 1,256 1,307 1,629 1,898 2,385 3,529 4,377 4,830 6,379
274 375 561 428 430 529 540 556 1,646 1,875 2,736 3,324
CWIP 60 20 17 20 39 39 95 742 279 711 355 143
Investments 171 170 239 428 427 195 99 118 44 495 480 1,229
346 390 360 380 410 866 1,163 969 1,561 1,296 1,259 1,683
Total Assets 852 955 1,177 1,256 1,307 1,629 1,898 2,385 3,529 4,377 4,830 6,379

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1 76 92 169 90 157 237 75 -64 750 571 894
3 -53 -16 -136 -24 85 -237 -172 -656 -1,094 -511 -1,235
-21 -17 -67 -39 -68 -81 -45 42 658 336 -47 344
Net Cash Flow -17 6 10 -6 -3 161 -45 -56 -61 -8 13 3
Free Cash Flow -61 58 -84 121 29 59 147 -501 -819 72 4 404
CFO/OP 28% 87% 78% 100% 74% 76% 71% 43% 8% 196% 122% 83%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 74 81 68 62 63 75 88 90 99 91 90 83
Inventory Days 96 89 136 110 91 127 129 149 197 150 117 118
Days Payable 113 112 94 92 58 79 77 85 103 122 118 140
Cash Conversion Cycle 57 57 110 80 96 123 140 154 193 119 89 61
Working Capital Days 39 37 4 43 58 88 113 109 140 45 25 178
ROCE % 11% 17% 22% 29% 21% 21% 22% 19% 20% 11% 12% 21%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Dec 2026 (P)
Number of Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Revenue Contribution from Exports
%
R&D Expenditure
INR Crores
Working Capital Cycle
Days
CDMO cGMP Capacity
KL
Total Production Volume
MT
Installed Hydrofluoric Acid (AHF) Capacity
TPA
Number of Customer Audits Completed (CDMO/Pharma)
Count
R32 Refrigerant Capacity Addition
MTPA
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
28.80% 28.80% 28.80% 28.80% 28.80% 28.43% 28.43% 28.43% 28.01% 27.11% 27.11% 27.10%
18.50% 19.20% 15.92% 15.57% 18.02% 18.23% 18.55% 20.16% 21.55% 22.15% 23.74% 23.78%
25.97% 26.01% 28.92% 28.60% 27.29% 28.18% 28.46% 30.04% 28.70% 29.57% 28.09% 27.61%
26.72% 25.98% 26.34% 27.00% 25.89% 25.15% 24.55% 21.37% 21.72% 21.16% 21.06% 21.49%
No. of Shareholders 1,49,5821,47,1911,72,8161,82,7591,71,9681,65,2311,59,0411,39,0071,38,3981,37,9811,37,7981,43,987

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls